Prognostic Factors and 10-Year Survival in Patients with Hepatocellular Carcinoma After Curative Hepatectomy

Journal of Gastrointestinal Surgery

Volumn 15, Issue 4, 2011, Pages 598-607

  Kim, Sung Hoon ^a   Choi, Sae Byeol ^b   Lee, Jae Gil ^a   Kim, Seung Up ^a   Park, Mi Suk ^a   Kim, Do Young ^a   Choi, Jin Sub ^a   Kim, Kyung Sik ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

10 Year survival; HBeAg; Hepatocellular carcinoma; Tumor size

Indexed keywords

HEPATITIS B(E) ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TUMOR; MALE; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HEPATITIS B E ANTIGENS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SURVIVAL RATE; YOUNG ADULT;

EID: 79953120380     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-011-1452-7     Document Type: Article

References (43)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55(2): 74-108.
2. Jee SH, Ohrr H, Sull JW, Samet JM. Cigarette Smoking, Alcohol Drinking, Hepatitis B, and Risk for Hepatocellular Carcinoma in Korea. J. Natl. Cancer Inst. 2004; 96(24): 1851-1856.
3. Office KNS. 2008 The statistical results for the cause of death. 2009.
4. Arii S, Yamaoka Y, Futagawa S, et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 2000; 32(6): 1224-1229.
5. Boutros C, Somasundar P, Garrean S, Saied A, Espat NJ. Microwave coagulation therapy for hepatic tumors: Review of the literature and critical analysis. Surgical Oncology 2010; 19(1): e22-e32.
6. Mahnken AH, Bruners P, Gunther RW. Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation. Dig Dis 2009; 27(2): 148-156.
7. Yamamoto J, Okada S, Shimada K, et al. Treatment strategy for small hepatocellular carcinoma: Comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology 2001; 34(4): 707-713.
8. Hasegawa K, Makuuchi M, Takayama T, et al. Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol 2008; 49(4): 589-594.
9. Schwarz RE, Smith DD. Trends in local therapy for hepatocellular carcinoma and survival outcomes in the US population. Am J Surg 2008; 195(6): 829-836.
10. Josep LL, Andrew B, Jordi B. Hepatocellular carcinoma. The Lancet 2003; 362(9399): 1907.
11. Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 2005; 25(2): 181-200.
12. Roayaie S, Frischer JS, Emre SH, et al. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg 2002; 235(4): 533-539.
13. Sharma P, Balan V, Hernandez JL, et al. Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl 2004; 10(1): 36-41.
14. Foster JH, Berman MM. Solid liver tumors. Major problems in clinical surgery 1977; 22: 1-342.
15. Belghiti J, Hiramatsu K, Benoist S, Massault PP, Sauvanet A, Farges O. Seven hundred forty-seven hepatectomies in the 1990 s: An update to evaluate the actual risk of liver resection. Journal of the American College of Surgeons 2000; 191(1): 38-46.
16. Imamura H, Seyama Y, Kokudo N, et al. One Thousand Fifty-Six Hepatectomies without Mortality in 8 Years. Archives of Surgery 2003; 138(11): 1198-1206.
17. Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: Analysis of 1, 803 consecutive cases over the past decade. Annals of Surgery 2002; 236(4): 397-407.
18. Metcalfe MS, Mullin EJ, Maddern GJ. Hepatectomy for metastatic noncolorectal gastrointestinal, breast and testicular tumours. ANZ Journal of Surgery 2006; 76(4): 246-250.
19. Truty MJ, Vauthey JN. Surgical resection of high-risk hepatocellular carcinoma: Patient selection, preoperative considerations, and operative technique. Annals of Surgical Oncology 2010; 17(5): 1219-1225.
20. Takano S, Oishi H, Kono S, et al. Retrospective analysis of type of hepatic resection for hepatocellular carcinoma. Br J Surg 2000; 87(1): 65-70.
21. Chang CH, Chau GY, Lui WY, Tsay SH, King KL, Wu CW. Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver. Arch Surg 2004; 139(3): 320-325; discussion 326.
22. Choi YM, Kang KC, Ahn SI, Lee KY, Hong KC, Choi SK. Clinical Analysis of Prognostic Factors in Hepatocellular Carcinoma. J Korean Surg Soc 2003; 65: 42-48.
23. Hanazaki K, Kajikawa S, Shimozawa N, et al. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. J Am Coll Surg 2000; 191(4): 381-388.
24. Hwang IS, Hong SW, Nah YW, Jang YG, Kim KH, Lee H. Analysis of 38 Long-Term Survivors after Liver resections for Hepatocellular Carcinomas. Korean J HBP Surg 2000; 4(2): 67-76.
25. Kanematsu T, Furui J, Yanaga K, Okudaira S, Shimada M, Shirabe K. A 16-year experience in performing hepatic resection in 303 patients with hepatocellular carcinoma: 1985-2000. Surgery 2002; 131(1 Suppl): S153-158.
26. Shimozawa N, Hanazaki K. Longterm prognosis after hepatic resection for small hepatocellular carcinoma. J Am Coll Surg 2004; 198(3): 356-365.
27. Nagasue N, Kohno H, Chang YC, et al. Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg 1993; 217(4): 375-384.
28. Shimada K, Sano T, Sakamoto Y, Kosuge T. A long-term follow-up and management study of hepatocellular carcinoma patients surviving for 10 years or longer after curative hepatectomy. Cancer 2005; 104(9): 1939-1947.
29. Lee JG, Kang CM, Park JS, et al. The actual five-year survival rate of hepatocellular carcinoma patients after curative resection. Yonsei Med J 2006; 47(1): 105-112.
30. Shah SA, Greig PD, Gallinger S, et al. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg 2006; 202(2): 275-283.
31. Shirabe K, Kanematsu T, Matsumata T, Adachi E, Akazawa K, Sugimachi K. Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. Hepatology 1991; 14(5): 802-805.
32. Fukuda S, Itamoto T, Amano H, et al. Clinicopathologic features of hepatocellular carcinoma patients with compensated cirrhosis surviving more than 10 years after curative hepatectomy. World Journal of Surgery 2007; 31(2): 345-352.
33. Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Annals of Surgery 1991; 214(2): 114-117.
34. Paquet KJ, Koussouris P, Mercado MA, Kalk -Fr J, Muting D, Rambach W. Limited hepatic resection for selected cirrhotic patients with hepatocellular or cholangiocellular carcinoma: A prospective study. British Journal of Surgery 1991; 78(4): 459-462.
35. Yasui M, Harada A, Torii A, Nakao A, Nonami T, Takagi H. Impaired liver function and long-term prognosis after hepatectomy for hepatocellular carcinoma. World Journal of Surgery 1995; 19(3): 439-443.
36. Hanazaki K, Matsushita A, Nakagawa K, Misawa R, Amano J. Risk factors of long-term survival and recurrence after curative resection of hepatocellular carcinoma. Hepatogastroenterology 2005; 52(62): 552-557.
37. Adachi E, Maeda T, Matsumata T, et al. Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology 1995; 108(3): 768-775.
38. Shirabe K, Shimada M, Kajiyama K, et al. Clinicopathologic features of patients with hepatocellular carcinoma surviving & 10 years after hepatic resection. Cancer 1998; 83(11): 2312-2316.
39. Cescon M, Cucchetti A, Grazi GL, et al. Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience. Arch Surg 2009; 144(10): 906-913.
40. Sun H-C, Zhang W, Qin L-X, et al. Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma. Journal of Hepatology 2007; 47(5): 684-690.
41. Wu JC, Huang YH, Chau GY, et al. Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma. J Hepatol 2009; 51(5): 890-897.
42. Portolani N, Coniglio A, Ghidoni S, et al. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg 2006; 243(2): 229-235.
43. Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000; 232(1): 10-24.